191 related articles for article (PubMed ID: 30892048)
21. Prediction of lung cancer based on serum biomarkers by gene expression programming methods.
Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH
Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226
[TBL] [Abstract][Full Text] [Related]
22. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
[TBL] [Abstract][Full Text] [Related]
23. Panel of serum metabolites discriminates cancer patients and healthy participants of lung cancer screening - a pilot study.
Roś-Mazurczyk M; Wojakowska A; Marczak Ł; Polański K; Pietrowska M; Polanska J; Dziadziuszko R; Jassem J; Rzyman W; Widlak P
Acta Biochim Pol; 2017; 64(3):513-518. PubMed ID: 28803255
[TBL] [Abstract][Full Text] [Related]
24. Serum lipidome screening in patients with stage I non-small cell lung cancer.
Klupczynska A; Plewa S; Kasprzyk M; Dyszkiewicz W; Kokot ZJ; Matysiak J
Clin Exp Med; 2019 Nov; 19(4):505-513. PubMed ID: 31264112
[TBL] [Abstract][Full Text] [Related]
25. Serum untargeted metabolomics reveal metabolic alteration of non-small cell lung cancer and refine disease detection.
Li J; Liu K; Ji Z; Wang Y; Yin T; Long T; Shen Y; Cheng L
Cancer Sci; 2023 Feb; 114(2):680-689. PubMed ID: 36310111
[TBL] [Abstract][Full Text] [Related]
26. Blood test shows high accuracy in detecting stage I non-small cell lung cancer.
Goebel C; Louden CL; Mckenna R; Onugha O; Wachtel A; Long T
BMC Cancer; 2020 Feb; 20(1):137. PubMed ID: 32085733
[TBL] [Abstract][Full Text] [Related]
27. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
[TBL] [Abstract][Full Text] [Related]
28. Carbonic anhydrase 1 is a promising biomarker for early detection of non-small cell lung cancer.
Wang DB; Lu XK; Zhang X; Li ZG; Li CX
Tumour Biol; 2016 Jan; 37(1):553-9. PubMed ID: 26232327
[TBL] [Abstract][Full Text] [Related]
29. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer.
Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ
Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307
[TBL] [Abstract][Full Text] [Related]
30. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
[TBL] [Abstract][Full Text] [Related]
31. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Li Y; Song X; Zhao X; Zou L; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296
[TBL] [Abstract][Full Text] [Related]
32. Identification a novel clinical biomarker in early diagnosis of human non-small cell lung cancer.
Jin Y; Yang Y; Su Y; Ye X; Liu W; Yang Q; Wang J; Fu X; Gong Y; Sun H
Glycoconj J; 2019 Feb; 36(1):57-68. PubMed ID: 30607521
[TBL] [Abstract][Full Text] [Related]
33. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
34. Study of early stage non-small-cell lung cancer using Orbitrap-based global serum metabolomics.
Klupczynska A; Dereziński P; Garrett TJ; Rubio VY; Dyszkiewicz W; Kasprzyk M; Kokot ZJ
J Cancer Res Clin Oncol; 2017 Apr; 143(4):649-659. PubMed ID: 28168355
[TBL] [Abstract][Full Text] [Related]
35. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
36. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
[TBL] [Abstract][Full Text] [Related]
37. Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer.
Liu WR; Zhang B; Chen C; Li Y; Ye X; Tang DJ; Zhang JC; Ma J; Zhou YL; Fan XJ; Yue DS; Li CG; Zhang H; Ma YC; Huo YS; Zhang ZF; He SY; Wang CL
Thorac Cancer; 2020 Nov; 11(11):3234-3242. PubMed ID: 32989915
[TBL] [Abstract][Full Text] [Related]
38. Lung cancer serum biomarker discovery using label-free liquid chromatography-tandem mass spectrometry.
Zeng X; Hood BL; Zhao T; Conrads TP; Sun M; Gopalakrishnan V; Grover H; Day RS; Weissfeld JL; Wilson DO; Siegfried JM; Bigbee WL
J Thorac Oncol; 2011 Apr; 6(4):725-34. PubMed ID: 21304412
[TBL] [Abstract][Full Text] [Related]
39. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
[TBL] [Abstract][Full Text] [Related]
40. Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis.
Blanco-Prieto S; Barcia-Castro L; Páez de la Cadena M; Rodríguez-Berrocal FJ; Vázquez-Iglesias L; Botana-Rial MI; Fernández-Villar A; De Chiara L
BMC Cancer; 2017 Dec; 17(1):823. PubMed ID: 29207990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
